Anna Rosén

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 20

Top Venues

European journal of human genetics : EJHG

Trials

Cancers

Journal of personalized medicine

Region Västerbotten

Umeå University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Region Västerbotten Sep 01 2017

Sweden

Senior consultant :: Public health and Regional cancer centre

Education History

Umeå University Dec 19 2006 - Dec 06 2012

Sweden

PHD :: Epidemiology and Global health

Publications

Charlotta Nääs, Jenny von Salomé, Anna Rosén
Patients' perceptions and practices of informing relatives: a qualitative study within a randomised trial on healthcare-assisted risk disclosure. European journal of human genetics : EJHG (2024)
Anna Öfverholm, Per Karsson, Anna Rosén
The experience of receiving a letter from a cancer genetics clinic about risk for hereditary cancer. European journal of human genetics : EJHG 32 (5) (2024)
Charlotta Nääs, Jenny von Salomé, Anna Rosén
Patients' perceptions and practices of informing relatives: a qualitative study within a randomised trial on healthcare-assisted risk disclosure. European journal of human genetics : EJHG 32 (4) (2024)
Charlotta Nääs, Jenny von Salomé, Anna Rosén
Patients' perceptions and practices of informing relatives: a qualitative study within a randomised trial on healthcare-assisted risk disclosure. European journal of human genetics : EJHG 32 (4) (2024)
Anna Öfverholm, Per Karsson, Anna Rosén
The experience of receiving a letter from a cancer genetics clinic about risk for hereditary cancer. European journal of human genetics : EJHG 32 (5) (2024)
Anna Öfverholm, Per Karsson, Anna Rosén
The experience of receiving a letter from a cancer genetics clinic about risk for hereditary cancer. European journal of human genetics : EJHG 32 (5) (2024)
Anna Öfverholm, Per Karsson, Anna Rosén
The experience of receiving a letter from a cancer genetics clinic about risk for hereditary cancer. European journal of human genetics : EJHG 32 (5) (2024)
Charlotta Nääs, Jenny von Salomé, Anna Rosén
Patients' perceptions and practices of informing relatives: a qualitative study within a randomised trial on healthcare-assisted risk disclosure. European journal of human genetics : EJHG 32 (4) (2024)
Anna Öfverholm, Per Karsson, Anna Rosén
The experience of receiving a letter from a cancer genetics clinic about risk for hereditary cancer. European journal of human genetics : EJHG (2024)
Charlotta Nääs, Jenny von Salomé, Anna Rosén
Patients' perceptions and practices of informing relatives: a qualitative study within a randomised trial on healthcare-assisted risk disclosure. European journal of human genetics : EJHG 32 (4) (2024)
Anna Öfverholm, Per Karsson, Anna Rosén
The experience of receiving a letter from a cancer genetics clinic about risk for hereditary cancer. European journal of human genetics : EJHG 32 (5) (2024)
Anna Öfverholm, Per Karsson, Anna Rosén
The experience of receiving a letter from a cancer genetics clinic about risk for hereditary cancer. European journal of human genetics : EJHG (2024)
Anna Rosén, Mateja Krajc, Hans Ehrencrona, Svetlana Bajalica-Lagercrantz
Public attitudes challenge clinical practice on genetic risk disclosure in favour of healthcare-provided direct dissemination to relatives. European journal of human genetics : EJHG (2023)
Carolina Hawranek, Hans Ehrencrona, Anna Öfverholm, Barbro Numan Hellquist, Anna Rosén
Direct letters to relatives at risk of hereditary cancer-study protocol for a multi-center randomized controlled trial of healthcare-assisted versus family-mediated risk disclosure at Swedish cancer genetics clinics (DIRECT-study). Trials 24 (1) (2023)
Carolina Hawranek, Hans Ehrencrona, Anna Öfverholm, Barbro Numan Hellquist, Anna Rosén
Direct letters to relatives at risk of hereditary cancer-study protocol for a multi-center randomized controlled trial of healthcare-assisted versus family-mediated risk disclosure at Swedish cancer genetics clinics (DIRECT-study). Trials 24 (1) (2023)
Carolina Hawranek, Hans Ehrencrona, Anna Öfverholm, Barbro Numan Hellquist, Anna Rosén
Direct letters to relatives at risk of hereditary cancer-study protocol for a multi-center randomized controlled trial of healthcare-assisted versus family-mediated risk disclosure at Swedish cancer genetics clinics (DIRECT-study). Trials 24 (1) (2023)
Meis Omran, Emma Tham, Yvonne Brandberg, Håkan Ahlström, Claudia Lundgren, Ylva Paulsson-Karlsson, Ekaterina Kuchinskaya, Gustav Silander, Anna Rosén, Fredrik Persson, Henrik Leonhardt, Marie Stenmark-Askmalm, Johanna Berg, Danielle van Westen, Svetlana Bajalica Lagercrantz, Lennart Blomqvist, null null
Whole-Body MRI Surveillance-Baseline Findings in the Swedish Multicentre Hereditary TP53 -Related Cancer Syndrome Study (SWEP53). Cancers 14 (2) (2022)
Carolina Hawranek, Johan Maxon, Andreas Andersson, Bethany Van Guelpen, Senada Hajdarevic, Barbro Numan Hellquist, Anna Rosén
Cancer Worry Distribution and Willingness to Undergo Colonoscopy at Three Levels of Hypothetical Cancer Risk-A Population-Based Survey in Sweden. Cancers 14 (4) (2022)
Carolina Hawranek, Senada Hajdarevic, Anna Rosén
A Focus Group Study of Perceptions of Genetic Risk Disclosure in Members of the Public in Sweden: "I'll Phone the Five Closest Ones, but What Happens to the Other Ten?" Journal of personalized medicine 11 (11) (2021)
Andreas Andersson, Carolina Hawranek, Anna Öfverholm, Hans Ehrencrona, Kalle Grill, Senada Hajdarevic, Beatrice Melin, Emma Tham, Barbro Numan Hellquist, Anna Rosén
Public support for healthcare-mediated disclosure of hereditary cancer risk information: Results from a population-based survey in Sweden. Hereditary cancer in clinical practice 18 (2020)

Anna Rosén.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Anna Rosén